Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I have not had time to catch up

Sorry gentlemen I respectfully disagree.

Remember that last email was a confirmation by Ken at Hawk from my first email asking the same question back in Dec. when he wasn't as emphatic with his reply.

I realize your interpretation basis is from the announcement made of trading restrictions, but remember those restricted are also the ones who would have to authorize a buyback too, whether for the company or themselves. And since they are restricted from trading, it stands to reason it carries over they are also restricted from trading even in the company's name.

Meanwhile, remember, Turley also suspended the buyback saying, I believe, that he/they wanted to put the cash to better use for the company...which by that I interpret as saving it for M and A activities.

That's just MHO on the subject but we can agree to disagree.

the whole second email and response went as follows...

Question:

Ken:

As per our other communications has there been any change to the status of PTSC being able to re-start their repurchasing of shares.

Thank You:

Answer:

"..My question is.does this mean the company cannot continue it's announced
buyback program of the stock also till then,.."
Yes, it is confirmed; Pursuant to the following:
"..In addition, consistent with applicable securities laws and Patriot's insider-trading policy, the company's directors, officers, employees and consultants who have knowledge of the terms of settlement are restricted from trading in PTSC shares until after the company's quarterly financial reports are publicly filed next April.."
Share
New Message
Please login to post a reply